How to buy Paragon 28 stock

Paragon 28, a medical device company focused on products for feet and ankles, completed its initial public offering, selling 7.812 million shares at $16 each. The stock trades on the NYSE under the ticker symbol FNA.

Paragon 28 stock price (NYSE: FNA)

Use our graph to track the performance of FNA stocks over time.

Paragon 28 shares at a glance

• Key figures

Information last updated 2023-03-25.

Latest market close	$16.51
52-week range	$12.35 - $21.49
50-day moving average more info button	$17.70
200-day moving average more info button	$18.28
Wall St. target price	$28.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.83

Buy Paragon 28 stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Paragon 28 stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Paragon 28 price performance over time

Historical closes compared with the close of $16.51 from 2023-03-29

1 week (2023-03-23)	-1.90%
1 month (2023-03-03)	-6.25%
3 months (2022-12-30)	-13.61%
6 months (2022-09-30)	-7.35%

1 year (2022-03-31)	-1.37%
2 years (2021-03-27)	N/A
3 years (2020-03-27)	N/A
5 years (2018-03-27)	N/A

Paragon 28 financials

Revenue TTM	$181.4 million
Gross profit TTM	$148.9 million
Return on assets TTM	-8.77%
Return on equity TTM	-40.42%
Profit margin	-37.12%
Book value	$1.81
Market capitalisation more info button	$1.5 billion

TTM: trailing 12 months

Paragon 28 share dividends

We're not expecting Paragon 28 to pay a dividend over the next 12 months.

You may also wish to consider:

• Stryker Corporation (SYK.US) (1.08% forward annual dividend yield)
• Zimmer Biomet (ZBH.US) (0.76% forward annual dividend yield)

Paragon 28 overview

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments.

Frequently asked questions

What percentage of Paragon 28 is owned by insiders or institutions?
Currently 42.109% of Paragon 28 shares are held by insiders and 34.96% by institutions. How many people work for Paragon 28?
Latest data suggests 463 work at Paragon 28. When does the fiscal year end for Paragon 28?
Paragon 28's fiscal year ends in December. Where is Paragon 28 based?
Paragon 28's address is: 14445 Grasslands Drive, Englewood, CO, United States, 80112 What is Paragon 28's ISIN number?
Paragon 28's international securities identification number is: US69913P1057